生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | RKI-1447 is a type I kinase inhibitor that binds ATP binding sites through interactions with hinge regions and DFG motifs. RKI-1447 inhibits phosphorylation of ROCK substrates mLC-2 and MYPT-1 in human cancer cells, but has no effect on phosphorylation levels of AKT, MEK, and S6 kinases at concentrations up to 10 μM. RKI-1447 is also highly selective in inhibiting Rock-mediated cytoskeletal recombination. RKI-1447 inhibits breast cancer cell migration, invasion and anchor-independent tumor growth [1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.06mL 0.61mL 0.31mL |
15.32mL 3.06mL 1.53mL |
30.64mL 6.13mL 3.06mL |
参考文献 |
---|